Galaxy Biomedical Investment Co., Ltd.
Symbol: 000806.SZ
SHZ
0.43
CNYMarket price today
-1.1415
P/E Ratio
0.0445
PEG Ratio
494.96M
MRK Cap
- 0.00%
DIV Yield
Galaxy Biomedical Investment Co., Ltd. (000806-SZ) Stock Split, History Data
Working capital analysis
In terms of working capital, Galaxy Biomedical Investment Co., Ltd. maintains a healthy position. The total current assets of the company are valued at $1462828859. This represents a growth rate of 29.176% compared to the previous year. Breaking down the current assets, the cash and investments are worth $78008348, exhibiting a growth rate of -7.764% year-on-year. The receivables, another significant portion of the current assets, are valued at $1177448659. The year-on-year growth rate for receivables is 55.052%. The inventory, which forms a critical part of the assets, is valued at $199623488. This represents a healthy year-on-year growth of -28.833% On the liabilities side, the company's current liabilities total $1043609631. This reflects a growth rate of 30.283% over the previous year, indicating the company's financial obligations are well under control.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|
Cash and investments | 78.01 | 84.58 | ||||
Receavebles | 1177.45 | 759.39 | ||||
Inventory | 199.62 | 280.50 | ||||
Other | 4.69 | 7.97 | ||||
Total Current Assets | 1462.83 | 1132.43 | ||||
Acc Payable | 285.36 | 261.00 | ||||
Short Term Debt | 189.20 | 109.26 | ||||
Other Current Liab | 569.05 | 18.11 | ||||
Current Liabilities | 1043.61 | 801.03 |
Capital Structure
When examining the capital structure of Galaxy Biomedical Investment Co., Ltd., it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $2009423105. When juxtaposed with the previous year, this marks a growth rate of 18.162%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $3324658250. Compared to the prior year, this reflects a growth rate of 27.412%. The long-term debt forms a sizable part of these liabilities, coming in at $8967712. Over the last year, the long-term debt has grown by -28.644%. On the asset side, the cash and equivalent reserves are worth $66553920. The year-on-year growth of these reserves is 6.160%. The company's common stock, another important asset, holds a value of $1099911762, growing at a rate of 0.000% from the previous year. Finally, the company's retained earnings stand at $-3607350284.27, marking a growth rate of 13.096% year-over-year. These earnings represent the profits that Galaxy Biomedical Investment Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$2,009.42
Total liabilities
$3,324,658,250.00
Long term debt
$8.97
Cash and eqv
$66,553,920.00
Goodwill
$0.00
Retained earnings
-$3,607,350,284.27
Common stock
$61.20
Enterprise Value
$3.58
Historical dividend key summary
Galaxy Biomedical Investment Co., Ltd.'s dividend per share is $0.017921, showing the earnings shared with shareholders per share. It has grown by 45.004% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Years | Q1 | Q2 | Q3 | Q4 | Total |
---|---|---|---|---|---|
2004 | 0.000 | 0.018 | 0.000 | 0.000 | 0.018 |
2002 | 0.000 | 0.012 | 0.000 | 0.000 | 0.012 |
2001 | 0.000 | 0.031 | 0.015 | 0.000 | 0.046 |
2000 | 0.000 | 0.018 | 0.000 | 0.000 | 0.018 |
1999 | 0.000 | 0.000 | 0.007 | 0.000 | 0.007 |
Net earnings per share (EPS)
Galaxy Biomedical Investment Co., Ltd. has an EPS of $-0.07, which signifies the profit allocated per share of common stock. With a growth rate of 78.169% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Years | Q1 | Q2 | Q3 | Q4 | Total |
---|---|---|---|---|---|
2023 | -0.0663 | - | - | - | -0.07 |
2022 | -0.0129 | 0.0079 | -0.0387 | -0.26 | -0.30 |
2021 | -0.0016 | 0 | 0 | 0 | -0.00 |
2020 | -0.0076 | 0 | 0.0365 | 0 | 0.03 |
2019 | -0.0113 | 0 | -0.0056 | 0 | -0.02 |
2018 | -0.0186 | 0 | -0.0506 | 0 | -0.07 |
2017 | -0.012 | 0 | 0.0216 | 0 | 0.01 |
2016 | -0.0115 | 0 | -0.0027 | 0 | -0.01 |
2015 | 0.0382 | 0 | 0.0027 | 0 | 0.04 |
2014 | -0.034 | 0 | 0.0281 | 0 | -0.00 |
2013 | 0.0016 | 0 | 0.0039 | 0 | 0.00 |
2012 | -0.018 | 0 | -0.002 | 0 | -0.02 |
2011 | -0.0225 | 0 | -0.0024 | 0 | -0.02 |
2010 | 0.0019 | 0 | -0.0034 | 0 | 0.00 |
2009 | 0.2 | 0 | -0.0312 | 0 | 0.17 |
2008 | 0.02 | 0 | -0.0243 | 0 | 0.00 |
2007 | 0.0273 | 0 | -0.0004 | 0 | 0.03 |
2006 | 0.0091 | 0 | 0.0038 | 0 | 0.01 |
2005 | 0.0279 | 0 | 0.0263 | 0 | 0.06 |
2004 | 0.0393 | 0 | 0.0378 | 0 | 0.08 |
2003 | 0.0235 | 0 | 0.0284 | 0 | 0.05 |
2002 | 0.0111 | 0 | 0 | 0 | 0.01 |
Galaxy Biomedical Investment Co., Ltd. (000806.SZ) stock split history
Understanding the historical stock splits of Galaxy Biomedical Investment Co., Ltd. (000806.SZ) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on June 24, 2008 with a ratio of 1.1:1. Throughout its history, the company has undergone 9 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
Date | Split Ratio |
---|---|
24 June 2008 | 1.1:1 |
11 July 2006 | 1.1:1 |
09 January 2006 | 12:10 |
28 June 2005 | 1.2:1 |
12 May 2004 | 11:10 |
23 May 2002 | 11:10 |
07 June 2000 | 13:10 |
07 September 1999 | 18:10 |
31 May 1999 | 1.1:1 |
Frequently Asked Question
What is the latest historical split date of the company?
The latest historical split date is N/A.
What is firm free cah flow per share (FCF per share)?
The free cah flow per share (FCF per share) is -0.372.
What is company revenue per share?
The company revenue per share is -0.294.
What are firm earnings per share?
The firm earnings per share is 1.037.
What is Galaxy Biomedical Investment Co., Ltd. (000806.SZ) ROIC (return on capital)?
Galaxy Biomedical Investment Co., Ltd. (000806.SZ) ROIC (return on capital) is -0.303.
What is dividend per share figure?
The dividend per share is 0.000
What is enterprise plowback ratio?
Galaxy Biomedical Investment Co., Ltd. (000806.SZ) plowback ratio is N/A
What is firm enterprise value (EV)?
The enterprise value (EV) is 3.579
What is company debt to equity ratio?
The debt to equity ratio is -0.162
What are debt ratio numbers?
The debt ratio is 0.107
What is company price to sales ratio?
The price to sales ratio is 0.465